Abstract
Sleep disturbance is a prevalent health problem (1–3) that occurs more frequently in women than in men (2,4–6). Insomnia increases particularly as women approach and pass through menopause (7–10). Insomnia in postmenopausal women, part of the climacteric syndrome, can occur, on the one hand, in association with hormonal changes (11,12); on the other hand, women are more likely to suffer from psychiatric disorders, such as major depression and anxiety disorders, which are also correlated with insomnia (5,13). Organic sleep disorders such as sleep-disordered breathing (SDB) resulting from a decrease of sex hormones in menopause may play an important role as well (14).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hochstrasser, B., [Epidemiology of sleep disorders]. Ther Umsch, 1993;50(10):679–683.
Ohayon, M.M. and T. Roth, What are the contributing factors for insomnia in the general population? J Psychosom Res, 2001;51(6): 45–755.
Zeitlhofer, J., A. Rieder, G. Kapfhammer, et al., [Epidemiology of sleep disorders in Austria]. Wien Klin Wochenschr, 1994;106(3):86–88.
Brugge, K., D. Kripke, S. Ancoli-Israel, and L. Garfinkel, The association of menopausal status and age with sleep. Sleep Res, 1989;18:208.
Owens, J.F. and K.A. Matthews, Sleep disturbance in healthy middle-aged women. Maturitas, 1998;30(1):41–50.
Saletu, B., N. Brandstatter, R. Frey, et al., [Clinical aspects of sleep disorders-experiences with 817 patients of an ambulatory sleep clinic; comment]. Wien Klin Wochenschr, 1997;109(11):390–399.
Kravitz, H.M., P.A. Ganz, J. Bromberger, L.H. Powell, K. Sutton-Tyrrell, and P.M. Meyer, Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause, 2003;10(1):19–28.
Kuh, D.L., M. Wadsworth, and R. Hardy, Women’s health in midlife: the influence of the menopause, social factors and health in earlier life. Br J Obstet Gynaecol, 1997;104(8):923–933.
Lugaresi, E., F. Cirignotta, and M. Zucconi, Good and poor sleepers: an epidemiological survey of San Marino population. In: Sleep/Wake Disorders: Natural History, Epidemiology, and Long-Term Evolution (C. Guilleminault and E. Lugaresi, eds.). Raven Press: New York, 1983.
Shaver, J.L. and S.N. Zenk, Sleep disturbance in menopause. J Womens Health Gend Based Med, 2000;9(2):109–118.
Manber, R. and R. Armitage, Sex, steroids, and sleep: a review. Sleep, 1999;22(5):540–555.
Moline, M., L. Broch, and R. Zak, Sleep problems across the life cycle in women. Curr Treat Options Neurol, 2004;6(4):319–330.
Krystal, A.D., Insomnia in women. Clin Cornerstone, 2003;5(3):41–50.
Guilleminault, C., L. Palombini, D. Poyares, and S. Chowdhuri, Chronic insomnia, postmenopausal women, and sleep disordered breathing: part 1. Frequency of sleep disordered breathing in a cohort. J Psychosom Res, 2002;53(1):611–615.
Bixler, E.O., A.N. Vgontzas, H.M. Lin, et al., Prevalence of sleep disorders in the Los Angeles metropolitan area. Am J Psychiatry, 1979;136(10):1257–1262.
Hunter, M., R. Battersby, and M. Whitehead, Relationships between psychological symptoms, somatic complaints and menopausal status. Maturitas, 1986;8(3):217–228.
Karacan, I., J.I. Thornby, M. Anch, et al., Prevalence of sleep disturbance in a primarily urban Florida County. Soc Sci Med, 1976;10(5):239–244.
Welstein, L., W. Dement, D. Redington, C. Guilleminault, and M. Mitler, Insomnia in the San Francisco Bay area: a telephone survey. In: Sleep/Wake Disorders: Natural History, Epidemiology and Long-Term Evolution, (C. Guilleminault, ed.), New York: Raven Press, 1983:73–85.
Moe, K.E., Reproductive hormones, aging, and sleep. Semin Reprod Endocrinol, 1999;17(4):339–348.
Jean-Louis, G., D.F. Kripke, J.D. Assmus, and R.D. Langer, Sleep-wake patterns among postmenopausal women: a 24-hour unattended polysomnographic study. J Gerontol A Biol Sci Med Sci, 2000;55(3):M120–M123.
Asplund, R. and H.E. Aberg, Body mass index and sleep in women aged 40 to 64 years. Maturitas, 1995;22(1):1–8.
Empson, J.A. and D.W. Purdie, Effects of sex steroids on sleep. Ann Med, 1999;31(2):141–145.
Jaszmann, L., N.D. Van Lith, and J.C. Zaat, The peri-menopausal symptoms: the statistical analysis of a survey. Med Gynaecol Sociol, 1969;10:268–277.
Ballinger, C.B., Psychiatric morbidity and the menopause; screening of general population sample. Br Med J, 1975;3(5979):344–346.
Thompson, J. and I. Oswald, Effect of estrogen on the sleep, mood and anxiety of menopausal women. Br Med J, 1977;2:1317–1319.
Schiff, I., Q. Regestein, D. Tulchinsky, and K.J. Ryan, Effects of estrogens on sleep and psychological state of hypogonadal women. JAMA, 1979;242(22):2405–2404.
Erlik, Y., I.V. Tataryn, D.R. Meldrum, P. Lomax, J.G. Bajorek, and H.L. Judd, Association of waking episodes with menopausal hot flushes. JAMA, 1981;245(17):1741–1744.
Antonijevic, I.A., G.K. Stalla, and A. Steiger, Modulation of the sleep electroencephalogram by estrogen replacement in postmenopausal women. Am J Obstet Gynecol, 2000;182(2):277–282.
Purdie, D.W., J.A. Empson, C. Crichton, and L. Macdonald, Hormone replacement therapy, sleep quality and psychological wellbeing. Br J Obstet Gynaecol, 1995;102(9):735–739.
Polo-Kantola, P., R. Erkkola, H. Helenius, K. Irjala, and O. Polo, When does estrogen replacement therapy improve sleep quality? Am J Obstet Gynecol, 1998;178(5):1002–1009.
Schulz, H., M. Jobert, K.W. Gee, and D.W. Ashbrook, Soporific effect of the neurosteroid pregnanolone in relation to the substance’s plasma level: a pilot study. Neuropsychobiology, 1996;34(2):106–112.
Steiger, A., L. Trachsel, J. Guldner, et al., Neurosteroid pregnenolone induces sleep-EEG changes in man compatible with inverse agonistic GABAA-receptor modulation. Brain Res, 1993;615(2):267–274.
Teichmann, A.T., Dienogest-Präklinik und Klinik eines neuen Gestagens [Dienogest-Preclinical and Clinical Characteristics of a New Progestin]. Berlin/New York: Walter de Gruyter, 1995.
Kupperman, H.S., B.B. Wetchler, and M.H. Blatt, Contemporary therapy of the menopausal syndrome. JAMA, 1959;171:1627–1637.
Saletu-Zyhlarz, G., P. Anderer, G. Gruber, et al., Insomnia related to postmenopausal syndrome and hormone replacement therapy: sleep laboratory studies on baseline differences between patients and controls and double-blind, placebo-controlled investigations on the effects of a novel estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone. J Sleep Res, 2003;12(3):239–254.
Saletu, B., P. Wessely, J. Grünberger, and M. Schulte, Erste klinische Erfahrungen mit einem neuen schlafansto×enden Benzodiazepin, Cinolazepam, mittels eines Selbstbeurteilungsbogens für Schlaf-und Aufwachqualität (SSA). Neuropsychiatrie, 1987;1(4):169–176.
Von Zerssen, D., D.M. Koeller, and E.R. Rey, Die Befindlichkeitsskala (B-S)-ein einfaches Instrument zur Objektivierung von Befindlichkeitsstörungen, insbesondere im Rahmen von Längsschnittuntersuchungen. Arzneim Forsch Drug Res, 1970;20:915–918.
Buysse, D.J., C.F. Reynolds, 3rd, T.H. Monk, S.R. Berman, and D.J. Kupfer, The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res, 1989;28(2):93–213.
Grünberger, J., Psychodiagnostik des Alkoholkranken. Ein methodischer Beitrag zur Bestimmung der Organizität in der Psychiatrie. Vienna: Maudrich, 1977.
Abt, K., Descriptive data analysis (DDA) in quantitative EEG studies. In: Statistics and Topography in Quantitative EEG (D. Samson-Dollfus et al., eds.). Amsterdam: Elsevier, 1988:150–160.
Hunter, M., The south-east England longitudinal study of the climacteric and postmenopause. Maturitas, 1992;14(2):117–126.
Hunter, M.S., Psychological and somatic experience of the menopause: a prospective study (corrected). Psychosom Med, 1990;52(3):357–367.
Kujak, J. and T. Young, The average month-to-month effect of menopausal symptoms on sleep complaints. Sleep, 1997;20(Suppl 1):384.
Feinberg, I., M. Braun, and R.L. Koresko, Vertical eye-movement during REM sleep: effects of age and electrode placement. Psychophysiology, 1969;5(5):556–561.
Tune, G.S., The influence of age and temperament on the adult human sleep-wakefulness pattern. Br J Psychol, 1969;60(4):31–441.
Webb, W.B., The different functional relationships of REM and stage 4 sleep. In: The Nature of Sleep (Jovanovic, ed.). Stuttgart: Fischer, 1973:256–258.
Rechtschaffen, A. and A. Kales, A Manual of Standardized Terminology, Technique and Scoring System for Sleep Stages. San Francisco: Brain Information Service University of California, 1968.
Anderer, P., B. Saletu, and R.D. Pascual-Marqui, Effect of the 5-HT(1A) partial agonist buspirone on regional brain electrical activity in man: a functional neuroimaging study using low-resolution electromagnetic tomography (LORETA). Psychiatry Res, 2000;100(2):81–96.
Saletu, B., P. Anderer, R. Frey, M. Krupka, and G. Klüsch, Zur Neurophysiologie des Schlafes/ Some remarks about the neurophysiology of sleep. Psychiatria Danubina, 1991;3(1–2):31–58.
Dietzel, M., B. Saletu, O.M. Lesch, W. Sieghart, and M. Schjerve, Light treatment in depressive illness. Polysomnographic, psychometric and neuroendocrinological findings. Eur Neurol, 1986;25(Suppl 2):93–103.
Reynolds, C.F., 3rd and D.J. Kupfer, Sleep research in affective illness: state of the art circa 1987. Sleep, 1987;10(3):199–215.
Saletu-Zyhlarz, G.M., M.H. Abu-Baker, P. Anderer, et al., Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone. Prog Neuropsychopharmacol Biol Psychiatry, 2002;26(2):249–260.
Saletu-Zyhlarz, G.M., M.H. Abu-Baker, P. Anderer, et al., Insomnia related to dysthymia: polysomnographic and psychometric comparison with normal controls and acute therapeutic trials with trazodone. Neuropsychobiology, 2001;44(3):139–149.
Saletu, B., P. Anderer, N. Brandstatter, et al., Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long-versus a short-half-life benzodiazepine (quazepam versus triazolam). Neuropsychobiology, 1994;29(2):69–90.
Saletu-Zyhlarz, G., B. Saletu, P. Anderer, et al., Nonorganic insomnia in generalized anxiety disorder. 1. Controlled studies on sleep, awakening and daytime vigilance utilizing polysomnography and EEG mapping. Neuropsychobiology, 1997;36(3):117–129.
Saletu-Zyhlarz, G.M., P. Anderer, P. Berger, G. Gruber, S. Oberndorfer, and B. Saletu, Nonorganic insomnia in panic disorder: comparative sleep laboratory studies with normal controls and placebo-controlled trials with alprazolam. Hum Psychopharmacol, 2000;15(4):241–254.
Saletu, M., C. Hauer, P. Anderer, et al., [Daytime tiredness correlated with nocturnal respiratory and arousal variables in patients with sleep apnea: polysomnographic and EEG mapping studies]. Wien Klin Wochenschr, 2000;112(6):281–289.
Saletu, B., P. Anderer, M. Saletu, et al., Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 1. Findings on objective and subjective sleep and awakening quality. Neuropsychobiology, 2000;41(4):181–189.
Saletu, M., P. Anderer, B. Saletu, et al., Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 2. Findings on periodic leg movements, arousals and respiratory variables. Neuropsychobiology, 2000;41(4):190–199.
Saletu, M., P. Anderer, B. Saletu, et al., Sleep laboratory studies in periodic limb movement disorder (PLMD) patients as compared with normals and acute effects of ropinirole. Hum Psychopharmacol, 2001;16(2):177–187.
Montplaisir, J., J. Lorrain, R. Denesle, and D. Petit, Sleep in menopause: differential effects of two forms of hormone replacement therapy. Menopause, 2001;8(1):10–16.
Polo-Kantola, P., R. Erkkola, K. Irjala, S. Pullinen, I. Virtanen, and O. Polo, Effect of short-term transdermal estrogen replacement therapy on sleep: a randomized, double-blind crossover trial in postmenopausal women. Fertil Steril, 1999;71(5):873–880.
Pickett, C.K., J.G. Regensteiner, W.D. Woodard, D.D. Hagerman, J.V. Weil, and L.G. Moore, Progestin and estrogen reduce sleep-disordered breathing in postmenopausal women. J Appl Physiol, 1989;66(4):1656–1661.
Lyons, H.A. and R. Antonio, The sensitivity of the respiratory center in pregnancy and after the administration of progesterone. Trans Assoc Am Physicians, 1959;72:173–180.
Block, A.J., J.W. Wynne, P.G. Boysen, S. Lindsey, C. Martin, and B. Cantor, Menopause, medroxyprogesterone and breathing during sleep. Am J Med, 1981;70(3):506–510.
Dolly, F.R. and A.J. Block, Medroxyprogesterone acetate and COPD. Effect on breathing and oxygenation in sleeping and awake patients. Chest, 1983;84(4):394–398.
Orr, W.C., N.K. Imes, and R.J. Martin, Progesterone therapy in obese patients with sleep apnea. Arch Intern Med, 1979;139(1):109–111.
Rajagopal, K.R., P.H. Abbrecht, and B. Jabbari, Effects of medroxyprogesterone acetate in obstructive sleep apnea. Chest, 1986;90(6):815–821.
Skatrud, J.B., J.A. Dempsey, C. Iber, and A. Berssenbrugge, Correction of CO2 retention during sleep in patients with chronic obstructive pulmonary diseases. Am Rev Respir Dis, 1981;124(3):260–268.
Strohl, K.P., M.J. Hensley, N.A. Saunders, S.M. Scharf, R. Braun, and R.H. Ingram, Jr., Progesterone administration and progressive sleep apneas. JAMA, 1981;245(12):1230–1232.
Rao, B.R., W.G. Wiest, and W.M. Allen, Progesterone “receptor” in rabbit uterus. I. Characterization and estradiol-17beta augmentation. Endocrinology, 1973;92(4):1229–1240.
Brodeur, P., M. Mockus, R. McCullough, and L.G. Moore, Progesterone receptors and ventilatory stimulation by progestin. J Appl Physiol, 1986;60(2):590–595.
Keefe, D.L., R. Watson, and F. Naftolin, Hormone replacement therapy may alleviate sleep apnea in menopausal women: a pilot study. Menopause, 1999;6(3):196–200.
Zeitlhofer, J., A. Schmeiser, G. Kapfhammer, J. Bolitschek, B. Saletu, and M. Keinze, Epidemiologie von Schlafstörungen in Osterreich. Neuropsychiatrie, 1996;10(1):43.
Rumbach, L., J. Krieger, and D. Kurtz, Auditory event-related potentials in obstructive sleep apnea: effects of treatment with nasal continuous positive airway pressure. Electroencephalogr Clin Neurophysiol, 1991; 80(5):454–457.
Walsleben, J.A., E.B. O’Malley, K. Bonnet, R.G. Norman, and D.M. Rapoport, The utility of topographic EEG mapping in obstructive sleep apnea syndrome. Sleep, 1993;16(8 Suppl):S76–S78.
Partinen, M. and C. Guilleminault, Daytime sleepiness and vascular morbidity at seven-year follow-up in obstructive sleep apnea patients. Chest, 1990;97(1):27–32.
Siebler, M. and A. Nachtmann, Cerebral hemodynamics in obstructive sleep apnea. Chest, 1993;103(4):1118–1119.
Kales, A., A.B. Caldwell, R.J. Cadieux, A. Vela-Bueno, L.G. Ruch, and S.D. Mayes, Severe obstructive sleep apnea-II: Associated psychopathology and psychosocial consequences. J Chronic Dis, 1985;38(5):427–434.
Millman, R.P., B.S. Fogel, M.E. McNamara, and C.C. Carlisle, Depression as a manifestation of obstructive sleep apnea: reversal with nasal continuous positive airway pressure. J Clin Psychiatry, 1989;50(9):348–351.
Bixler, E.O., A.N. Vgontzas, H.M. Lin, et al., Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med, 2001;163(3 Pt 1):608–613.
Bixler, E.O., A.N. Vgontzas, H.M. Lin, et al., Association of hypertension and sleep-disordered breathing. Arch Intern Med, 2000;160(15):2289–2295.
Campbell, S., Double-blind psychometric studies on the effects of natural oestrogens on postmenopausal women. In: Management of the Menopause and the Postmenopausal Years (S. Campbell, ed.). Lancaster: MTP Press, 1977:149–158.
Crown, S. and A.H. Crisp, Manual of the Crown-Crisp Experiential Index. London: Hodder and Stoughton, 1979.
Wiklund, I., G. Berg, M. Hammar, J. Karlberg, R. Lindgren, and K. Sandin, Long-term effect of transdermal hormonal therapy on aspects of quality of life in postmenopausal women. Maturitas, 1992;14(3):225–236.
Saletu, B., P. Anderer, D. Gruber, M. Metka, J. Huber, and G. M. Saletu-Zyhlarz, Hormone replacement therapy and vigilance: double-blind, placebo-controlled EEG-mapping studies with an estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone in menopausal syndrome patients. Maturitas, 2002;43(3):165–181.
Anderer, P., H.V. Semlitsch, B. Saletu, et al., Effects of hormone replacement therapy on perceptual and cognitive event-related potentials in menopausal insomnia. Psychoneuroendocrinology, 2003;28(3):419–445.
Linzmayer, L., H.V. Semlitsch, B. Saletu, et al., Double-blind, placebo-controlled psychometric studies on the effects of a combined estrogen-progestin regimen versus estrogen alone on performance, mood and personality of menopausal syndrome patients. Arzneimittelforschung, 2001;51(3):238–245.
Baumgartner, A., M. Dietzel, B. Saletu, et al., Influence of partial sleep deprivation on the secretion of thyrotropin, thyroid hormones, growth hormone, prolactin, luteinizing hormone, follicle stimulating hormone, and estradiol in healthy young women. Psychiatry Res, 1993;48(2):153–178.
Saletu, B. and G.M. Saletu-Zyhlarz, Was Sie Schon Immer Über Schlaf Wissen Wollten. 2001, Vienna: Ueberreuter.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Saletu-Zyhlarz, G. et al. (2006). Insomnia During Menopause. In: Attarian, H.P. (eds) Sleep Disorders in Women. Current Clinical Neurology. Humana Press. https://doi.org/10.1007/978-1-59745-115-4_18
Download citation
DOI: https://doi.org/10.1007/978-1-59745-115-4_18
Publisher Name: Humana Press
Print ISBN: 978-1-58829-592-7
Online ISBN: 978-1-59745-115-4
eBook Packages: MedicineMedicine (R0)